bitcoin finance- Top See results about

Since the release of "Keba Article", the refinancing of the first unprofitable enterprise in Shanghai Stock Exchange has been approved, and Dizhe Medicine announced that the company's private placement plan has been approved by Shanghai Stock Exchange. This is the first time that the refinancing of the unprofitable enterprise on the Shanghai Stock Exchange has been approved since the release of "Keba Article". (science and technology innovation board Daily)Traders increased their bets on the Fed's interest rate cut. After the CPI report was released, swap traders increased their bets on the Fed's interest rate cut before the end of 2025. They now predict that by that time, they will cut interest rates by 87 basis points, which means that the Federal Reserve will cut interest rates by 25 basis points next week. In 2025, there will be another two interest rate cuts of 25 basis points each time, which is less than the four times proposed by Fed officials in the latest quarterly bitmap in September.Modern Investment: Xu Qing, the independent director of the company, was subject to disciplinary review and supervision investigation. According to the announcement of Modern Investment, Xu Qing, the independent director of the company, was suspected of serious violation of discipline and law, and is currently subject to disciplinary review by the Disciplinary Committee of Hunan Branch of Industrial and Commercial Bank of China and supervision investigation by Zhuzhou Municipal Supervision Committee. Xu Qing did not hold any other positions in the company except as an independent director, chairman of the Nomination Committee of the Board of Directors, member of the Strategy Committee of the Board of Directors and member of the Audit Committee of the Board of Directors, and did not participate in the daily operation and management of the company. The company will pay attention to the subsequent progress and fulfill its information disclosure obligations in a timely manner in strict accordance with relevant regulations.

Tesla Applied for the trademark of robot action toy, and the enterprise search app showed that Tesla Co., Ltd. recently applied for registering a trademark of "TESLA BOT ACTION FIGURE", which is classified as fitness equipment internationally. At present, the trademark status is in the process of registration application. According to media reports, recently, Tesla robot action toys were sold in official stores for 40 dollars. According to the official description, the toy is a "mini version" of Optimus Gen 2 humanoid robot, which is made in a ratio of 1:10.The price of gold is expected to break through the market. The key data of the United States are expected tonight, and the price of gold is basically flat on Wednesday. The market expects the key inflation data of the United States, which may affect the general expectation of interest rate cuts and provide more clues for the outlook in 2025. Rhona O‘Connell, an analyst at StoneX, said that the market is concerned about the upcoming inflation data and will pay attention to President Powell's post-meeting comments next week for further policy insights. O' Connell added that the price of gold was once stagnant but showing signs of recovery. The recent rebound was driven by geopolitical risks, and the price of gold reached the upper limit of the range, but did not break through the high point. Kyle Rodda, a financial market analyst in Capital.com, said: "The expected data almost gives the Fed a green light to cut interest rates next week, which may be a gold price catalyst." Goldman Sachs said that the main downside risk of predicting that gold will be $3,000 per ounce by the end of 2025 is that the Fed will cut interest rates, not that the dollar will strengthen. Goldman Sachs predicts: "If the Fed cuts interest rates again, the price of gold will rise to $2,890 per ounce."Guanghua Technology: Breaking the dependence on the import of key raw materials for daily chemicals and meeting the high-end diversified needs. In the global oral care industry, tin salt is a key raw material, which is widely used in toothpaste and professional oral care products because of its excellent effects of preventing dental caries, anti-sensitivity, reducing gingival bleeding and fighting gingivitis. However, the domestic market has long relied on imports for this key raw material, and the production cost remains high, which seriously restricts the competitiveness of our oral care products in the international market. Guanghua Technology has made a breakthrough in this field, successfully breaking the long-term dependence on imports, taking the lead in becoming a domestic enterprise to realize large-scale production of this special effect ingredient, significantly reducing the cost of key raw materials for customers, and further enhancing the competitiveness of China manufacturing in the international market.

Spot gold just broke through the $2,690.00/oz mark, and the latest price was $2,689.72/oz, down 0.15% in the day.The minimum acceptable price of the two-year national debt issued by the Ministry of Finance in Hong Kong is 100.62 yuan. The minimum acceptable price of the five-year national debt issued by the Ministry of Finance in Hong Kong is 102.41 yuan.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)